Elizabeth R. Tucker et al.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Clinical Cancer Research 2023, vol. 29, issue 7
doi: 10.1158/1078-0432.ccr-22-2274
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Elizabeth R. Tucker et al.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Clinical Cancer Research 2023, vol. 29, issue 7
doi: 10.1158/1078-0432.ccr-22-2274